drugset / Trial / NCT00190944

Effects of Teriparatide on Distal Radius Fracture Healing

NCT00190944 ↗

Phase 2 Completed 105 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

Effects of Teriparatide on Distal Radius Fracture Healing

Timeline

Start
2004-12
Primary completion
—
Completion
2007-06

Outcome

Missed primary endpoint

paper The primary hypothesis that teriparatide 40 microg would shorten the time to cortical bridging was not supported. PMID 19594305 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic 20 ug —
Subject Teriparatide Protein / enzyme biologic 40 ug —

Indications

No indication recorded.